75 related articles for article (PubMed ID: 9419442)
1. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12.
Leonard JP; Waldburger KE; Schaub RG; Smith T; Hewson AK; Cuzner ML; Goldman SJ
Crit Rev Immunol; 1997; 17(5-6):545-53. PubMed ID: 9419442
[TBL] [Abstract][Full Text] [Related]
2. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively.
Constantinescu CS; Hilliard B; Ventura E; Wysocka M; Showe L; Lavi E; Fujioka T; Scott P; Trinchieri G; Rostami A
Clin Immunol; 2001 Jan; 98(1):23-30. PubMed ID: 11141323
[TBL] [Abstract][Full Text] [Related]
3. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way.
Berghmans N; Dillen C; Heremans H
J Neuroimmunol; 2006 Jul; 176(1-2):63-75. PubMed ID: 16764944
[TBL] [Abstract][Full Text] [Related]
4. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis.
Wildbaum G; Youssef S; Grabie N; Karin N
J Immunol; 1998 Dec; 161(11):6368-74. PubMed ID: 9834127
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
7. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
Korn T; Magnus T; Toyka K; Jung S
J Leukoc Biol; 2004 Nov; 76(5):950-60. PubMed ID: 15328336
[TBL] [Abstract][Full Text] [Related]
8. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R
J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
10. T- and B-cell nonresponsiveness to self-alphaB-crystallin in SJL mice prevents the induction of experimental allergic encephalomyelitis.
van Stipdonk MJ; Willems AA; Verbeek R; Boog CJ; van Noort JM
Cell Immunol; 2000 Sep; 204(2):128-34. PubMed ID: 11069720
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
[TBL] [Abstract][Full Text] [Related]
12. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
14. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
15. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
[TBL] [Abstract][Full Text] [Related]
16. Antisecretory factor expression is regulated by inflammatory mediators and influences the severity of experimental autoimmune encephalomyelitis.
Davidson TS; Hickey WF
J Leukoc Biol; 2004 Oct; 76(4):835-44. PubMed ID: 15277566
[TBL] [Abstract][Full Text] [Related]
17. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
[TBL] [Abstract][Full Text] [Related]
18. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis.
Hofstetter HH; Toyka KV; Gold R
Neurosci Lett; 2006 Jan; 391(3):127-30. PubMed ID: 16198481
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.
Smith T; Hewson AK; Kingsley CI; Leonard JP; Cuzner ML
Am J Pathol; 1997 Jun; 150(6):1909-17. PubMed ID: 9176384
[TBL] [Abstract][Full Text] [Related]
20. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
